|
AstraZeneca Set To Gain From New Asthma Drug
Seeking Alpha AstraZeneca and Rigel Pharmaceuticals (RIGL) have agreed to work together on a chronic asthma drug. The drug in question is R256, which is Rigel's "inhaled … |
View full post on asthma – Google News